Doctor's Bio
Board Certifications
American Board of Internal Medicine
Affiliations
Emory
Education & Training
- Medical School: Hacettepe University Medical School
- Residency: St. Francis Hospital(Evanston)
Fellowships
St. Francis Hospital(Evanston)
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617.
Gerke MB, Marra A, Liu Y, Bedmutha A, Brown JT, Nazha B, Berchuck JE, Parikh RB, Ahmed S, Ciuro JA, Hartman C, McClintock GR, Caulfield S, Kucuk O, Carthon BC, Schuster DM, Muzahir S, Bilen MA
Cancer. 2026;132(8):e70410.
PMID: 41989013 - Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.
Brown JT, Nazha B, Ferreira AC, Armeson K, Hill EG, Ogretmen B, Mehrotra S, Brisendine A, Magrath G, Plasse TF, Gourdin TS, Kucuk O, Lilly M
Cancer medicine. 2026;15(4):e71633.
PMID: 41981710 - Impact of integrated weed control methods on yield performance and sustainable weed suppression in sugar beet ( L.).
Küçük Ö, Bozdoğan O
Frontiers in plant science. 2026;
PMID: 41756652 - Clinical outcomes of lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancer.
Gerke MB, Bedmutha A, Marra A, Liu Y, Brown JT, Nazha B, Berchuck JE, Parikh RB, Ahmed S, Ciuro JA, Hartman C, McClintock GR, Caulfield S, Kucuk O, Carthon BC, Schuster DM, Muzahir S, Bilen MA
The oncologist. 2026;
PMID: 41630499 - An increase in splenic volume after first-line immunotherapy is associated with worse PFS in patients with metastatic renal cell carcinoma.
Palmateer G, Yildirim A, Goodstein T, Patil D, Patel S, Joshi S, Narayan V, Brown JT, Nazha B, Ahmed SS, Ciuro J, Carthon BC, Kucuk O, Kissick H, Ogan K, Bilen MA, Master VA
The oncologist. 2026;
PMID: 41495002 - Baseline geriatric 8 (G8) screening tool predicts overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitors.
Rhee CH, Goyal S, Liu Y, Martini DJ, Shabto JM, Nazha B, Kucuk O, Carthon BC, Bilen MA, Brown JT
The oncologist. 2025;
PMID: 41442452 - [F]-Fluciclovine or [Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial.
Jani AB, Dhere VR, Goyal S, Schreibmann E, Patel PR, Hershatter B, Shelton JW, Hanasoge S, Sebastian NT, Patel SA, Halkar R, Cooper S, Fielder B, Abiodun-Ojo OA, Lawal I, Mushtaq A, Master VA, Joshi SS, Kucuk O, Bilen MA, Schuster DM
European urology. 2026;89(4):368-377.
PMID: 41412908 - Vitamin A5: Evidence, Definitions, Gaps, and Future Directions.
Bohn T, Rohn S, Böhm V, Despotovic M, de Lera AR, Krezel W, Kucuk O, Bánáti D, Rühl R
Nutrients. 2025;
PMID: 40732942 - Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer.
Li X, Mamouni K, Zhao R, Bai L, Chen Y, Wu Y, Xie ZR, Sautto GA, Liu D, Bowen NJ, Danaher A, Li D, Cook N, Grayson S, Zhu J, Coleman IM, Nelson PS, Bao Q, Zhou J, Osunkoya AO, Kucuk O, Gera L, Wu D
British journal of cancer. 2025;132(12):1188-1199.
PMID: 40253488 - Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
Bilen MA, Vo BT, Liu Y, Greenwald R, Davarpanah AH, McGuire D, Shiradkar R, Li L, Midya A, Nazha B, Brown JT, Williams S, Session W, Russler G, Caulfield S, Joshi SS, Narayan VM, Filson CP, Ogan K, Kucuk O, Carthon BC, Del Balzo L, Cohen A, Boyanton A, Prokhnevska N, Cardenas MA, Sobierajska E, Jansen CS, Patil DH, Nicaise E, Osunkoya AO, Kissick HT, Master VA
Nature cancer. 2025;6(3):432-444.
PMID: 40016487
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.